Aldesulfone sodium: Difference between revisions
Content deleted Content added
Script assisted update of identifiers for the Chem/Drugbox validation project (updated: ''). |
Merged content to Sulfoxone, redirecting; uncontested 2021 proposal; same drug (easy-merge) Tag: New redirect |
||
| (17 intermediate revisions by 11 users not shown) | |||
| Line 1: | Line 1: | ||
#REDIRECT [[Sulfoxone]] |
|||
{{Drugbox |
|||
| Verifiedfields = changed |
|||
| verifiedrevid = 401594884 |
|||
| IUPAC_name = [4-[4-(sulfinomethylamino) phenyl] sulfonylphenyl] aminomethanesulfinic acid |
|||
| image = Aldesulfonesodium.png |
|||
{{R from merge}} |
|||
<!--Clinical data--> |
|||
| tradename = |
|||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|||
| pregnancy_US = <!-- A / B / C / D / X --> |
|||
| pregnancy_category = |
|||
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 --> |
|||
| legal_UK = <!-- GSL / P / POM / CD --> |
|||
| legal_US = <!-- OTC / Rx-only --> |
|||
| legal_status = |
|||
| routes_of_administration = Oral |
|||
<!--Pharmacokinetic data--> |
|||
| bioavailability = |
|||
| protein_bound = 69% |
|||
| metabolism = [[Liver|Hepatic]] |
|||
| elimination_half-life = 3 to 8 hours |
|||
| excretion = |
|||
<!--Identifiers--> |
|||
| CASNo_Ref = {{cascite|correct|CAS}} |
|||
| CAS_number = 144-75-2 |
|||
| ATC_prefix = J04 |
|||
| ATC_suffix = BA03 |
|||
| ATC_supplemental = |
|||
| PubChem = 8954 |
|||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|||
| DrugBank = APRD00704 |
|||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|||
| ChemSpiderID = 8610 |
|||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = 57OWB0Q221 |
|||
| KEGG_Ref = {{keggcite|correct|kegg}} |
|||
| KEGG = D02521 |
|||
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|||
| ChEMBL = 1200580 |
|||
<!--Chemical data--> |
|||
| C=14 | H=16 | N=2 | O=6 | S=3 |
|||
| molecular_weight = 404.485 g/mol |
|||
| smiles = [Na+].[Na+].[O-]S(=O)CNc1ccc(cc1)S(=O)(=O)c2ccc(NCS([O-])=O)cc2 |
|||
| InChI = 1/C14H16N2O6S3.2Na/c17-23(18)9-15-11-1-5-13(6-2-11)25(21,22)14-7-3-12(4-8-14)16-10-24(19)20;;/h1-8,15-16H,9-10H2,(H,17,18)(H,19,20);;/q;2*+1/p-2 |
|||
| InChIKey = AZBNFLZFSZDPQF-NUQVWONBAG |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|||
| StdInChI = 1S/C14H16N2O6S3.2Na/c17-23(18)9-15-11-1-5-13(6-2-11)25(21,22)14-7-3-12(4-8-14)16-10-24(19)20;;/h1-8,15-16H,9-10H2,(H,17,18)(H,19,20);;/q;2*+1/p-2 |
|||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|||
| StdInChIKey = AZBNFLZFSZDPQF-UHFFFAOYSA-L |
|||
}} |
|||
'''Aldesulfone sodium''' (or '''sulfoxone''') is an [[antibiotic]] used in the treatment of [[leprosy]]. |
|||
Sulfoxone sodium was introduced in Japan in 1948.<ref>PMID 12412600</ref> |
|||
==References== |
|||
{{reflist}} |
|||
{{Antimycobacterials}} |
|||
{{Nucleic acid inhibitors}} |
|||
[[Category:Sulfonamide antibiotics]] |
|||
{{antiinfective-drug-stub}} |
|||
Latest revision as of 14:52, 15 March 2022
Redirect to:
- From a merge: This is a redirect from a page that was merged into another page. This redirect was kept in order to preserve the edit history of this page after its content was merged into the content of the target page. Please do not remove the tag that generates this text (unless the need to recreate content on this page has been demonstrated) or delete this page.
- For redirects with substantive page histories that did not result from page merges use {{R with history}} instead.